Skip to content

12th Annual Focus on Pharmacology Conference

This program happened in the past, and no dates are currently scheduled.

Select this button to navigate the sections of this page

Conference ID

D6765

Purpose

Participants are saying
“I have attended this for six years. I always enjoy the speakers. Love Dr. Fitzgerald and the virtual platform as well.”
2021 Participant

The purpose of this conference is to provide pharmacology information in multiple areas and to promote clinical excellence through improving the quality of care to patients.

Audience

The primary audience is nurse practitioners, physician assistants and advanced practice clinicians; however, the program content is relevant to the broader health care community.

Highlights

This activity includes two hours of opioid continuing education.

Keynote Presenter

A headshot of Dr. Margaret Fitzgerald

Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP

Dr. Fitzgerald’s presentations cover the following areas of expertise:

  • NP Certification Preparation
  • Clinical Pharmacology
  • NP Professional Issues
  • Pathophysiology
  • Laboratory Diagnosis

Dr. Fitzgerald is the founder and principal speaker of Fitzgerald Health Education Associates (FHEA), an international provider of nurse practitioner certification preparation and continuing education for healthcare providers. An internationally recognized presenter, Dr. Fitzgerald has provided thousands of programs for numerous professional organizations, universities, and national and state healthcare associations on a wide variety of topics including clinical pharmacology, clinical assessment, laboratory diagnosis, healthcare, and nurse practitioner practice. For more than 25 years, she has provided graduate-level pharmacology courses for NP students at a number of universities. In addition, she practices at the Greater Lawrence Family Health Center, Lawrence, MA, providing multigenerational primary and urgent care. Dr. Fitzgerald also holds a Doctor of Nursing Practice (DNP) from Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, where she received the Alumni Association Award for Clinical Excellence and is also an Adjunct Associate Professor. Dr. Fitzgerald is a member of the Pharmacy and Therapeutics Committee at AllWays Health Partners in Boston, MA.

Participants are saying
“Love Margaret Fitzgerald. Probably the best speaker I have heard. She does a great job putting together her slides and presenting them. Very thorough.”
2021 Participant

Dr. Fitzgerald is the recipient of the National Organization of Nurse Practitioner Faculties’ Lifetime Achievement Award, given in recognition of vision and accomplishments in successfully developing and promoting the nurse practitioner role, the American College of Nurse Practitioner’s Sharp Cutting Edge Award, the Outstanding Nurse Award for Clinical Practice by the Merrimack Valley Area Health Education Council, and one of the 50 Leaders in 50 Years by the Solomont School of Nursing, UMass Lowell. In addition, Dr. Fitzgerald received the Loretta C. Ford Lifetime Achievement Award from the National Nurse Practitioner Symposium for demonstrating longevity, integrity, professional achievement, and advocacy in advanced practice nursing. She is also a Fellow of the American Academy of Nursing and a charter fellow in the Fellows of the American Association of Nurse Practitioners. Dr. Fitzgerald is a Professional Member of the National Speakers Association and is the first nurse practitioner to earn the Certified Speaking Professional (CSP) designation in recognition of excellence and integrity as a speaker. She is also certified by the American Board of Comprehensive Care as a Diplomate of Comprehensive Care (DCC), a designation available to DNP graduates who are licensed advanced practice registered nurses (APRN) and nationally certified in an APRN specialty. Dr. Fitzgerald is an editorial board member of The Nurse Practitioner, American Nurse Today, Prescriber’s Letter, and Journal of Doctoral Nursing Practice.

She is widely published, with more than 200 articles, book chapters, monographs, and audio and video programs to her credit. Her book, Nurse Practitioner Certification Exam Prep (now in the 6th edition), received the American Journal of Nursing Book of the Year Award for Advanced Practice Nursing and has been published in English and Korean. She has provided consultation to nursing organizations worldwide. Dr. Fitzgerald is an active member of numerous national and local professional organizations.

Agenda and Objectives

Friday, April 8, 2022

  • 7:45 a.m. | Opening Remarks
    Carol Forsyth, MSN, CRNP, FNP-BC
  • 8 a.m. | Concurrent Session 1
    1A Pediatric Track

    Pediatric Asthma Management Guidelines and Updates
    Amy Dooley, DO

    Objectives
    • Describe diagnostic and treatment strategies used in the pediatric asthma population.
    • Review latest National Heart, Lung, and Blood Institute (NHLBI) updates in asthma management and how they impact care.
    1B Acute Care Track

    Therapeutic Sedation in COVID-19 Patients
    Ashley L. Quintili, PharmD, BCPS, BCCCP

    Objectives
    • Identify indication for sedation in the intensive care unit (ICU).
    • Describe the pharmacologic properties of various sedatives.
    • Identify sedation challenges in COVID-19.
    1C Primary Care Track

    Deprescribing: Does Your Patient Still Need That Medicine?
    Jayson Loeffert, DO

    Objectives
    • Describe the concept of deprescribing and how it can benefit your patients.
    • Analyze a patient’s medication list effectively and identify dangerous or unnecessary medications.
    • Demonstrate a plan to safely remove dangerous or unnecessary medications from the medication list.
  • 9 a.m. | Concurrent Session 2
    2A Pediatric Track

    Vaccine Updates and Hesitancy
    Shawn Cooper, DO

    Objectives
    • Review root causes for vaccine hesitancy.
    • Discuss several approaches to approaching vaccine-hesitant parents/patients.
    2B Acute Care Track

    Medical Management of the End-Stage Renal Disease (ESRD) Patient
    Brooke Olenowski, PA-C

    Objectives
    • Review the diagnosis of ESRD and renal replacement therapy options.
    • Describe medical complications seen in ESRD patients and what pharmaceutical options are available to manage these complications.
    2C Primary Care Track

    Optimize Heart Failure (HF) Medical Therapy and Keep Your Patients at Home
    Suzanne Frazier, MS, CRNP, CHFN, NP-C

    Objectives
    • Differentiate pharmacologic optimization for systolic heart failure.
    • Describe how to prescribe diuretics and develop a diuretic action plan.
  • 10 a.m. | Break/Visit Exhibits
  • 10:30 a.m. | Risk Evaluation and Mitigation Strategies for Opioid Management of Chronic
    Non-Cancer Pain

    David M. Giampetro, MD

    Objectives
    • Describe and be able to perform an appropriate assessment for a patient who is considering or is already on opioid therapy.
    • Describe how to initiate, modify, and monitor opioid therapy, including the most common and serious side effects and aberrant drug-related behaviors.
  • 11:30 a.m. | Concurrent Session 3
    3A Pediatric Track

    Pediatric Hidradenitis Suppurativa
    Laurie A. Krnjaic, MSN, CRNP

    Objectives
    • Discuss how to diagnosis hidradenitis suppurativa in children and adolescents.
    • Explain first-line treatment for hidradenitis suppurativa.
    3B Acute Care Track

    Intravenous Sedation and Analgesia in the Intensive Care Unit
    Amit Prasad, MD

    Objectives
    • Recognize the pharmacodynamics and pharmacokinetics of the most common sedatives and analgesics used in the ICU.
    • Explain the proper dosing, mechanism of action, and side effects of these drugs.
    3C Primary Care Track

    Nuts and Bolts of Osteoporosis
    Dean Campbell, MSN, RN, CRNP

    Objectives
    • Identify high-risk patient populations.
    • List different treatment options.
  • 12:30 p.m. | Adjournment

Saturday, April 9, 2022

  • 7:45 a.m. | Opening Remarks
    Carol Forsyth, MSN, CRNP, FNP-BC
  • 8 a.m. | Keynote Presenter
    Guideline Update
    Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP

    Objectives
    • Describe select updated clinical guidelines.
    • Apply the recommendations of select updated clinical guidelines.
    • Identify the pharmacologic implications of these updated clinical guidelines.
  • 9 a.m. | Poster Presentations
  • 10 a.m. | Break/Visit Exhibits
  • 10:30 a.m. | Keynote Presenter
    Hot Topics in Drug Therapy
    Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP

    Objectives
    • Describe characteristics of and recommendations for the use of new medications.
    • Recognize new indications and cautions for established products.
    • Identify warnings concerning the use of established medications.
  • 11:30 a.m. | Recognizing Addiction
    Sarah Kawasaki, MD

    Objectives
    • Distinguish the difference between addiction and dependence.
    • Identify the evidence for monitoring patients on controlled substances.
    • Explain the approach to the patient who demonstrates signs of addiction.
    • Discuss what Penn State is doing to address opioid use disorder.
  • 12:30 p.m. | Adjournment

Committee Chair

Carol Forsyth, MSN, CRNP, FNP-BC
Committee Chair
Family Nurse Practitioner
Penn State Bone and Joint Institute

Committee

Directed and Supported by the Advanced Practice Advisory Board

Betsy Avinash, MSN, CRNP, FNP-C
Family Nurse Practitioner
Department of Urology
Penn State Health Milton S. Hershey Medical Center

Participants are saying
“This is a great conference! I plan to attend every year I can!”
2021 Participant

Jackie Bailey, MSN, BSN, AGACNP-BC
Adult Critical Care Nurse Practitioner
Department of Neurosurgery
Penn State Health Milton S. Hershey Medical Center

David Brinton, MSN, CRNP, FNP-BC, AGACNP-BC
Manager, Advanced Practice Providers
Department of Surgery
Penn State Health Milton S. Hershey Medical Center

Suzanne Frazier, MS, CRNP, CHFN, NP-C
Heart Failure Nurse Practitioner, Heart Failure Disease Management Program
Penn State Heart and Vascular Institute

Rachel Fultz, MSPAS, PA-C
Physician Assistant
Division of Pediatric Pulmonology
Penn State Health Children’s Hospital

David M. Giampetro, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Associate Professor, Department of Neurology
Director of Inpatient and Outpatient Opioid Stewardship
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Jaime Halin, MHS, PA-C
Physician Assistant
Penn State Bone and Joint Institute

Robin Kingston, MSN, CRNP, CPNP
Pediatric Nurse Practitioner
Pediatric Home Ventilator Program
Penn State Health Children’s Hospital

Marnie ODonnell, MS, PA-C
Physician Assistant, Children’s Heart Group
Pediatric Electrophysiology
Penn State Health Children’s Hospital

Bonnie Wilson, MS, CRNP, AGACNP-BC, ANP-C
Acute Care Nurse Practitioner
Penn State Health Milton S. Hershey Medical Center

Faculty

Dean Campbell, MSN, RN, CRNP
Nurse Practitioner
Department of Orthopaedics and Rehabilitation
Penn State Health Milton S. Hershey Medical Center

Shawn Cooper, DO
Assistant Professor, Department of Pediatrics
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Amy Dooley, DO
Assistant Professor, Department of Pediatrics
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Suzanne Frazier, MS, CRNP, CHFN, NP-C
Heart Failure Nurse Practitioner, Heart Failure Disease Management Program
Penn State Heart and Vascular Institute

David M. Giampetro, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Associate Professor, Department of Neurology
Director of Inpatient and Outpatient Opioid Stewardship
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Sarah Kawasaki, MD
Assistant Professor, Department of Psychiatry and Behavioral Health
Director, Addiction Services
Assistant Professor, Department of Psychiatry and Internal Medicine
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Laurie A. Krnjaic, MSN, CRNP
Nurse Practitioner
Department of Dermatology
Penn State Health Milton S. Hershey Medical Center

Jayson Loeffert, DO
Assistant Professor, Department of Family and Community Medicine
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Brooke Olenowski, PA-C
Physician Assistant
Department of Medicine
Division of Nephrology
Penn State Health Milton S. Hershey Medical Center

Amit Prasad, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Ashley L. Quintili, PharmD, BCPS, BCCCP
Adult Critical Care Clinical Coordinator
Clinical Specialist-Surgical/Anesthesia ICU
PGY2 Residency Director – Critical Care
Penn State Health Milton S. Hershey Medical Center

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 14 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Friday, April 8, 2022 – 10 AMA PRA Category 1 Credit(s)
  • Saturday, April 9, 2022 – 4 AMA PRA Category 1 Credit(s)

Nurse practitioners please note:

This program includes a maximum of 14 hours of pharmacology continuing education as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). All presentations qualify for pharmacology education.

  • Friday, April 8, 2022 – 10 hours pharmacy continuing education
  • Saturday, April 9, 2022 – 4 hours pharmacy continuing education

This program includes a maximum of 2 hours of identification of addiction or the practices of prescribing or dispensing of opioids as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). Please see the agenda for the presentations marked with (opioid).

  • Friday, April 8, 2022 – 1 hour opioid continuing education
  • Saturday, April 9, 2022 – 1 hour opioid continuing education

Nurses using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing at: ce.med.psu.edu/nurse-credits.

These credits meet the criteria set by the ANCC, American Nurses Credentialing Center as contact hours that are acceptable for renewal certification. Additional information is available through the American Nurses Credentialing Center.

  • Friday, April 8, 2022 – 10 Hours
  • Saturday, April 9, 2022 – 4 Hours

Fees

The fee is per person, $150 for Friday and Saturday or $75 for Saturday only. It includes the cost of instruction and online handout materials.

To receive the following reduced student rates, email verification of student status to ContinuingEd@pennstatehealth.psu.edu.
$100 For Friday and Saturday; $50 for Saturday only.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Thursday, April 7, 2022, will incur a $25 late fee.

Cancellations received after Friday, April 1, 2022, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, April 5, 2022.

Evaluation

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

COVID-19

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow health care facility guidelines, including masks. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue, which may not require masks. We ask that all participants respect that some attendees may still choose to wear masks for off-campus activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Access (ADA)

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

Disclosure and Conflict of Interest (COI and Educational Balance)

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to mitigate any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D6765

Jump to ...